Yousef Najajreh, Al Quds University
Reducing Body Weight and Glucose Levels & Improving Cognitive Function
Small molecule, obesity
Successful demonstration of efficacy in mice
US Granted ...
Prof. Yaron Ilan, Department of Human Nutrition and Metabolism and Liver Unit Hadassah Hospital
Cannabinoids/endocannabinoids and/or capsaicin or cannabidiol, improve both liver and brain functions
Nutrition and Metabolism, ...
About the company
Raziel Therapeutics is a clinical-stage pharmaceutical company developing a
proprietary drug (NCE) that after a single injection into subcutaneous fat,
converts white adipose tissue (WAT) into thermogenic, brown-like adipose ...
Fatty liver, metabolic syndrome, obesity
Drug at preclinical stage
U.S. Provisional Patent Application No. 61/921,558
6 million Americans with NASH, and more than 25 million expected ...
Superactive High Afinity Leptin antagonist, mutein, multiple sclerosis, inflammatory bowel syndrome, rheumatoid arthritis, fibrosis, cardiovascular disease, CKD Cachexia, Osteoarthritis
(1) In vivo tests in animal ...
Peptide/Protein, Inflammation, Autoimmunity, Diabetes
Feasibility demonstrated in mouse models of both type 1 and type 2 diabetes (abbreviated T1D and T2D, respectively)
Provisional Patent ...
New targets and novel classes of compounds for Type 2 Diabetes
Life Sciences; DiabetesLaboratory for Pharmacological Diabetes Research. Institute for Drug Research, Dept. of Pharmacology School of Pharmacy, Faculty of Medicine, the ...
Show better therapeutic activity
Formulation, Oncology / Cancer
Early stages – cell culture tests
Filed in the US
The global market for cancer drugs is expected to grow 12-15% annually ...
Additional information will be supplied upon request